Rock Springs Capital Management LP Aclaris Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

$1.67 Billion
Q1 2025

A detailed history of Rock Springs Capital Management LP transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 5,046,309 shares of ACRS stock, worth $6.16 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

5,046,309

Previous 6,204,309 18.66%

Holding current value

$6.16 Million

Previous $15.4 Million 49.82%

% of portfolio

0.46%

Previous 0.61%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.53 - $2.6 $1.77 Million - $3.01 Million	-1,158,000 Reduced 18.66%	5,046,309 $7.72 Million
Q4 2024 Feb 14, 2025	BUY	$1.15 - $4.59 $3.97 Million - $15.8 Million	3,450,814 Added 125.32%	6,204,309 $15.4 Million
Q1 2024 May 15, 2024	SELL	$0.92 - $1.44 $225,400 - $352,800	-245,000 Reduced 8.17%	2,753,495 $3.41 Million
Q4 2023 Feb 14, 2024	SELL	$0.64 - $6.49 $615,650 - $6.24 Million	-961,954 Reduced 24.29%	2,998,495 $3.15 Million
Q3 2023 Nov 14, 2023	SELL	$6.56 - $10.95 $9,184 - $15,329	-1,400 Reduced 0.04%	3,960,449 $27.1 Million
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $4,242 - $10,770	600 Added 0.02%	3,961,849 $32.1 Million
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $445,687 - $621,302	34,100 Added 0.87%	3,961,249 $62.4 Million
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $631,088 - $1.06 Million	62,115 Added 1.61%	3,927,149 $54.8 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $35,911 - $66,071	3,687 Added 0.1%	3,865,034 $66.6 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $713,071 - $1.07 Million	58,115 Added 1.53%	3,861,347 $56.1 Million
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $547,509 - $769,296	40,920 Added 1.09%	3,803,232 $68.5 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $3.3 Million - $5.72 Million	193,120 Added 5.41%	3,762,312 $66.1 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $5.23 Million - $24.8 Million	893,092 Added 33.37%	3,569,192 $89.9 Million
Q4 2020 Feb 16, 2021	BUY	$2.65 - $7.61 $1.59 Million - $4.56 Million	599,793 Added 28.89%	2,676,100 $17.3 Million
Q3 2020 Nov 16, 2020	BUY	$1.5 - $2.71 $648,438 - $1.17 Million	432,292 Added 26.29%	2,076,307 $5.34 Million
Q2 2020 Aug 14, 2020	BUY	$1.04 - $1.73 $45,775 - $76,145	44,015 Added 2.75%	1,644,015 $2.66 Million
Q4 2019 Feb 14, 2020	SELL	$1.02 - $1.97 $1.4 Million - $2.71 Million	-1,374,754 Reduced 46.21%	1,600,000 $3.02 Million
Q3 2019 Nov 14, 2019	BUY	$0.79 - $2.47 $747,935 - $2.34 Million	946,754 Added 46.68%	2,974,754 $3.21 Million
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $698,640 - $2.32 Million	328,000 Added 19.29%	2,028,000 $4.44 Million
Q1 2019 May 15, 2019	BUY	$5.63 - $7.84 $2.09 Million - $2.91 Million	370,600 Added 27.88%	1,700,000 $10.2 Million
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $2.83 Million - $6.92 Million	449,400 Added 51.07%	1,329,400 $9.82 Million
Q3 2018 Nov 14, 2018	BUY	$14.38 - $20.89 $345,120 - $501,360	24,000 Added 2.8%	880,000 $12.8 Million
Q2 2018 Aug 14, 2018	BUY	$16.46 - $20.33 $5.37 Million - $6.63 Million	326,000 Added 61.51%	856,000 $17.1 Million
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $1.96 Million - $2.95 Million	115,000 Added 27.71%	530,000 $9.29 Million
Q4 2017 Feb 14, 2018	SELL	$21.47 - $27.8 $536,750 - $695,000	-25,000 Reduced 5.68%	415,000 $10.2 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $10.1 Million - $12.7 Million	440,000	440,000 $11.4 Million

Others Institutions Holding ACRS

# of Institutions

113

Shares Held

95.1M

Call Options Held

35.4K

Put Options Held

32K

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $81.3M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Account

Rock Springs Capital Management LP Aclaris Therapeutics, Inc. Transaction History